Thailand · Delayed Price · Currency is THB Healthlead PCL Statistics
Total Valuation
Healthlead PCL has a market cap or net worth of THB 1.53 billion. The enterprise value is 1.30 billion.
| Market Cap | 1.53B |
| Enterprise Value | 1.30B |
Important Dates
The next estimated earnings date is Thursday, May 14, 2026.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | Mar 11, 2026 |
Share Statistics
Healthlead PCL has 254.55 million shares outstanding. The number of shares has decreased by -1.30% in one year.
| Current Share Class | 254.55M |
| Shares Outstanding | 254.55M |
| Shares Change (YoY) | -1.30% |
| Shares Change (QoQ) | -0.73% |
| Owned by Insiders (%) | 73.71% |
| Owned by Institutions (%) | 0.20% |
| Float | 67.06M |
Valuation Ratios
The trailing PE ratio is 20.69.
| PE Ratio | 20.69 |
| Forward PE | n/a |
| PS Ratio | 0.67 |
| PB Ratio | 1.58 |
| P/TBV Ratio | 1.62 |
| P/FCF Ratio | 9.48 |
| P/OCF Ratio | 7.90 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.38, with an EV/FCF ratio of 8.05.
| EV / Earnings | 16.65 |
| EV / Sales | 0.57 |
| EV / EBITDA | 6.38 |
| EV / EBIT | 11.72 |
| EV / FCF | 8.05 |
Financial Position
The company has a current ratio of 3.40, with a Debt / Equity ratio of 0.33.
| Current Ratio | 3.40 |
| Quick Ratio | 2.23 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 1.57 |
| Debt / FCF | 1.98 |
| Interest Coverage | 6.66 |
Financial Efficiency
Return on equity (ROE) is 7.89% and return on invested capital (ROIC) is 11.60%.
| Return on Equity (ROE) | 7.89% |
| Return on Assets (ROA) | 4.55% |
| Return on Invested Capital (ROIC) | 11.60% |
| Return on Capital Employed (ROCE) | 8.73% |
| Weighted Average Cost of Capital (WACC) | 5.80% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 3 |
| Asset Turnover | 1.50 |
| Inventory Turnover | 5.63 |
Taxes
In the past 12 months, Healthlead PCL has paid 20.64 million in taxes.
| Income Tax | 20.64M |
| Effective Tax Rate | 20.95% |
Stock Price Statistics
The stock price has increased by +2.63% in the last 52 weeks. The beta is 0.35, so Healthlead PCL's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | +2.63% |
| 50-Day Moving Average | 6.49 |
| 200-Day Moving Average | 7.06 |
| Relative Strength Index (RSI) | 29.98 |
| Average Volume (20 Days) | 122,128 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Healthlead PCL had revenue of THB 2.27 billion and earned 77.86 million in profits. Earnings per share was 0.29.
| Revenue | 2.27B |
| Gross Profit | 583.49M |
| Operating Income | 110.57M |
| Pretax Income | 98.50M |
| Net Income | 77.86M |
| EBITDA | 153.46M |
| EBIT | 110.57M |
| Earnings Per Share (EPS) | 0.29 |
Balance Sheet
The company has 549.33 million in cash and 318.41 million in debt, with a net cash position of 230.92 million or 0.91 per share.
| Cash & Cash Equivalents | 549.33M |
| Total Debt | 318.41M |
| Net Cash | 230.92M |
| Net Cash Per Share | 0.91 |
| Equity (Book Value) | 967.60M |
| Book Value Per Share | 3.70 |
| Working Capital | 644.18M |
Cash Flow
In the last 12 months, operating cash flow was 193.24 million and capital expenditures -32.19 million, giving a free cash flow of 161.05 million.
| Operating Cash Flow | 193.24M |
| Capital Expenditures | -32.19M |
| Depreciation & Amortization | 42.89M |
| Net Borrowing | -53.89M |
| Free Cash Flow | 161.05M |
| FCF Per Share | 0.63 |
Margins
Gross margin is 25.71%, with operating and profit margins of 4.87% and 3.43%.
| Gross Margin | 25.71% |
| Operating Margin | 4.87% |
| Pretax Margin | 4.34% |
| Profit Margin | 3.43% |
| EBITDA Margin | 6.76% |
| EBIT Margin | 4.87% |
| FCF Margin | 7.09% |
Dividends & Yields
This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 3.76%.
| Dividend Per Share | 0.22 |
| Dividend Yield | 3.76% |
| Dividend Growth (YoY) | 29.41% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 59.39% |
| Buyback Yield | 1.30% |
| Shareholder Yield | 5.06% |
| Earnings Yield | 5.10% |
| FCF Yield | 10.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Healthlead PCL has an Altman Z-Score of 4.52 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.52 |
| Piotroski F-Score | 6 |